• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

肝细胞癌：根治性治疗后预防复发的药物和策略。

Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment.

机构信息

Department of Surgery, University of Regensburg Medical Center, Regensburg, Germany.

出版信息

Liver Transpl. 2011 Nov;17 Suppl 3:S10-2. doi: 10.1002/lt.22411.

DOI:10.1002/lt.22411
PMID:21850696
Abstract
  1. Adjuvant/neoadjuvant chemotherapy. 2. Neoadjuvant transarterial chemoembolization. 3. Kinase inhibitors (eg, sorafenib). 4. Antiviral treatment. 5.Immunosuppressive treatment after liver transplantation. 6. Disseminated tumor cells: the basis for innovative treatment options?
摘要
  1. 辅助/新辅助化疗。2. 新辅助经动脉化疗栓塞。3. 激酶抑制剂（如索拉非尼）。4. 抗病毒治疗。5. 肝移植后的免疫抑制治疗。6. 播散性肿瘤细胞：创新治疗选择的基础？

相似文献

1
Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment.肝细胞癌：根治性治疗后预防复发的药物和策略。
Liver Transpl. 2011 Nov;17 Suppl 3:S10-2. doi: 10.1002/lt.22411.
2
Current strategies for preventing the recurrence of hepatocellular carcinoma after liver transplantation.肝移植后预防肝细胞癌复发的当前策略。
Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):145-9. doi: 10.1016/s1499-3872(15)60345-9.
3
Antiviral therapy after curative resection for patients with hepatitis B-related hepatocellular carcinoma.乙型肝炎相关肝细胞癌患者根治性切除术后的抗病毒治疗。
Br J Surg. 2013 May;100(6):724-5. doi: 10.1002/bjs.9105. Epub 2013 Mar 8.
4
Prevention of new hepatocellular carcinoma with concomitant antiviral therapy in chronic hepatitis B patients whose initial tumor was successfully ablated.
Int J Cancer. 2011 Feb 1;128(3):739-42. doi: 10.1002/ijc.25382.
5
Adjuvant treatment after orthotopic liver transplantation: is it really necessary?原位肝移植后的辅助治疗：真的有必要吗？
Oncology (Williston Park). 2009 Dec;23(14):1276-81.
6
Adjuvant iodine-131-labeled lipiodol for prevention of intrahepatic recurrence of hepatocellular carcinoma: which is the best treatment schedule?
Hepatology. 2005 Jun;41(6):1433; author reply 1433-4. doi: 10.1002/hep.20692.
7
Interferon: benefit beyond hepatitis therapy?
Am J Gastroenterol. 2001 Dec;96(12):3435-6. doi: 10.1111/j.1572-0241.2001.05371.x.
8
[Diagnosis and treatment of hepatocellular carcinoma].[肝细胞癌的诊断与治疗]
Dtsch Med Wochenschr. 2004 Feb 20;129(8):368-72. doi: 10.1055/s-2004-819893.
9
Treatment of early hepatocellular carcinoma: How to predict and prevent recurrence.早期肝细胞癌的治疗：如何预测和预防复发。
Dig Liver Dis. 2010 Jul;42 Suppl 3:S249-57. doi: 10.1016/S1590-8658(10)60513-0.
10
Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.索拉非尼联合哺乳动物雷帕霉素靶蛋白抑制剂治疗肝移植后复发性肝细胞癌的疗效和安全性。
Liver Transpl. 2012 Jan;18(1):45-52. doi: 10.1002/lt.22434.

引用本文的文献

1
Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.肝细胞癌的肝移植——影响预后和无病生存期的因素
World J Gastroenterol. 2015 Nov 14;21(42):12071-82. doi: 10.3748/wjg.v21.i42.12071.
2
Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection.术前外周血单核细胞计数升高预示着肝细胞癌根治性切除术后预后不良。
BMC Cancer. 2014 Oct 3;14:744. doi: 10.1186/1471-2407-14-744.
3
[Operative therapy of hepatocellular carcinoma].
[肝细胞癌的手术治疗]
Radiologe. 2014 Jul;54(7):673-8. doi: 10.1007/s00117-014-2653-3.
4
Use of adjuvant sorafenib in liver transplant recipients with high-risk hepatocellular carcinoma.辅助性索拉非尼在高危肝细胞癌肝移植受者中的应用。
J Transplant. 2014;2014:913634. doi: 10.1155/2014/913634. Epub 2014 Apr 10.
5
Mitochondrial metabolism in the noncancerous liver determine the occurrence of hepatocellular carcinoma: a prospective study.非癌性肝脏中的线粒体代谢决定肝细胞癌的发生：一项前瞻性研究。
J Gastroenterol. 2014 Mar;49(3):502-10. doi: 10.1007/s00535-013-0791-4. Epub 2013 Mar 30.
6
Extended postinterventional tumor necrosis-implication for outcome in liver transplant patients with advanced HCC.晚期 HCC 肝移植患者介入后肿瘤坏死范围扩大的影响。
PLoS One. 2013;8(1):e53960. doi: 10.1371/journal.pone.0053960. Epub 2013 Jan 22.
7
Synergistic growth inhibition by sorafenib and vitamin K2 in human hepatocellular carcinoma cells.索拉非尼与维生素 K2 对人肝癌细胞的协同生长抑制作用。
Clinics (Sao Paulo). 2012 Sep;67(9):1093-9. doi: 10.6061/clinics/2012(09)18.